Heather Hasson - Jun 16, 2023 Form 4 Insider Report for FIGS, Inc. (FIGS)

Signature
/s/ Danielle Warner, Attorney-in-Fact for Heather L. Hasson
Stock symbol
FIGS
Transactions as of
Jun 16, 2023
Transactions value $
-$1,068,474
Form type
4
Date filed
6/21/2023, 06:14 PM
Previous filing
Jun 15, 2023
Next filing
Jun 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIGS Class A Common Stock Options Exercise $97.2K +114K +8.59% $0.85* 1.45M Jun 16, 2023 Direct F1
transaction FIGS Class A Common Stock Sale -$950K -114K -7.91% $8.31 1.33M Jun 16, 2023 Direct F2
transaction FIGS Class A Common Stock Options Exercise $25.3K +29.8K +2.24% $0.85* 1.36M Jun 20, 2023 Direct
transaction FIGS Class A Common Stock Sale -$241K -29.8K -2.19% $8.09 1.33M Jun 20, 2023 Direct F3
holding FIGS Class A Common Stock 8.34K Jun 16, 2023 Held by the Heather Hasson Revocable Trust
holding FIGS Class A Common Stock 141 Jun 16, 2023 Held by Hollywood Capital Partners LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIGS Stock Option (Right to Buy) Options Exercise $0 -114K -18.43% $0.00 506K Jun 16, 2023 Class A Common Stock 114K $0.85 Direct F5
transaction FIGS Stock Option (Right to Buy) Options Exercise $0 -29.8K -5.89% $0.00 476K Jun 20, 2023 Class A Common Stock 29.8K $0.85 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 All but 264,045 of these securities are RSUs, each representing a contingent right to receive one share of the Issuer's Class A Common Stock. Upon vesting and settlement of certain of the RSUs, certain shares of the Issuer's Class A Common Stock held by the Reporting Person may be exchanged at a 1:1 ratio for shares of the Issuer's Class B Common Stock at the election of the Reporting Person pursuant to the Equity Award Exchange Right Agreement. In addition to the securities reported in this column, the Reporting Person beneficially owns 2,617,943 shares of the Issuer's Class B Common Stock, which are convertible at any time at the option of the Reporting Person into one share of Class A Common Stock, and 12,963,431 shares underlying vested options.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.15 to $8.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.235 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The Reporting Person is a managing member of Hollywood Capital Partners LLC and disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F5 All shares underlying this option have vested.

Remarks:

This Form 4 relates to sales effected pursuant to Ms. Hasson's 10b5-1 plan previously disclosed on her Schedule 13D/A filed on 3/21/2023.